Recent advances in label-free biosensors applications in protein biosynthesis and HTS screening

Protein Biosynthesis

Volumn , Issue , 2009, Pages 163-194

  O'Malley, Shawn ^a  

^a Corning Incorporated ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84895369883     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (129)

1. Buerk, D.G. Biosensor: Theory and application. Technomic Publishing Co., 1993. Lancaster, PA.
2. Wolfbeis, O. Fiber optic chemical sensors and biosensors. Vol I and II. CRC Press. (1991) Boca Raton, Fl
3. Gauglitz, G. and Proll, G. Strategies for label-free optical detection. Adv. Biochem. Engin. Biotechnol. 2008. 109:395-432.
4. Cooper, M.A. Non-optical screening platforms: the next wave in label-free screening? Drug Discov. Today. 2006.11(23/24): 1068-1074.
5. Park, K-Y, Kim, M-S. and Choi, S-Y. Fabrication and characterization of MOSFET protein chip for detection of ribosomal protein. Biosensors and Bioelectronics. 2005. 20: 2111-2115.
6. Brousseau, L.C. Label-free " digital detection" of single-molecule DNA hybridization with a single electron transistor. J. Amer. Chem. Soc. 2006. 128: 11346-11347.
7. Grow AE, Wood LL, Claycomb JL, Thompson PA. New biochip technology for label-free detection of pathogens and their toxins. J Microbiol Methods. 2003. 53(2):221-33.
8. Huang GS, Wang MT, Hong MY. A versatile QCM matrix system for online and high-throughput bio-sensing. Analyst. 2006. 131(3): 382-7.
9. Burg TP, Godin M, Knudsen SM, Shen W, Carlson G, Foster JS, Babcock K, Manalis SR. Weighing of biomolecules, single cells and single nanoparticles in fluid. Nature. 2007 Apr 26;446(7139):1066-9.
10. Simpkins, F., Czechowicz, J., Liotta, L. and Kohn, E. SELDI-TOF mass spectrometry for cancer biomarker discovery and serum proteomic diagnostics. Summary Pharmacogenomics. 2005, 6 (6): 647-653.
11. Tang N, Tornatore P, Weinberger S.R. Current developments in SELDI affinity technology. Mass spectrometry reviews. 2005. 23 (1): 34-44.
12. Shiau, A.K., Massari, M.E. and Ozbal, C.C. Back to Basics: Label-free technologies for small molecule screening. Combinatorial Chemistry & High Throughput Screening. 2008. 11, 231-237.
13. Olsen, J., Macek, B., Lange, O., Makarov, A., Horning, S. and Mann, M. Higher-energy C-trap dissociation for peptide modification analysis. Nature Methods. 2007. 4(9): 709-712.
14. Bakhtiar R, Guan, Z. Electron capture dissociation mass spectrometry in characterization of post-translational modifications. Biochem Biophys Res Commun. 2005. 19; 334(1):1-8.
15. Roddy, T., Horvath, C.R., Stout, S., Kenney, K., Ho, P., Zhang, J-H, Vickers, C., Kaushik, V., Hubbard, B., and Wang, Y.K. Mass spectrometry techniques for label-free high thoughput screening in drug discovery. Anal. Chem. 2007. 79: 8207-8213.
16. Ozbal CC, LaMarr WA, Linton JR, Green DF, Katz A, Morrison TB, Brenan CJ. High throughput screening via mass spectrometry: a case study using acetylcholinesterase. Assay Drug Dev Technol. 2004. 2(4):373-81.
17. Min DH, Tang WJ, Mrksich M. Chemical screening by mass spectrometry to identify inhibitors of anthrax lethal factor. Nat Biotechnol. 2004. 22(6):717-23.
18. Makara, G.M. and Athanasopoulos, J. Improving success rates for lead generation using affinity binding technologies. Curr Opin Biotechnol. 2005.16(6):666-73.
19. Annis, D.A., Nickbarg, E., Yang, X., Ziebell, M.R. and Whitehurst, C.E. Affinity selection-mass spectrometry screening techniques for small molecule drug discovery. Curr. Opin. Chem. Biol. 2007. 11: 518-526.
20. Cancilla, M. T., Erlanson, D. A. Tethering: Fragment-based drug discovery by mass spectrometry, pp. 305-320 in Methods and Principles in Medicinal Chemistry Volume 36: Mass Spectrometry in Medicinal Chemistry, Wanner, K. and Hafner, G, eds. Wiley-VCH (Weinheim, Germany, 2007). Series editors Mannhold, R., Kubinyi, H., Folkers, G.
21. Kaltashov, I.A. and Eyles, S.J. Mass spectrometry in biophysics: conformation and dynamics of biomolecules. Wiley-Interscience series on mass spectrometry. 2005. Hoboken, NJ.
22. Moore, J., Abdul-Manan, N., Fejzo, J., Jacobs, M., Lepre, C. Peng, J. and Xie, X. Leveraging structural approaches: applications of NMR-based screening and X-ray crystallography for inhibitor design. J. Synchrotron Rad. 2004. 11: 97-100.
23. Fejzo, J., Lepre, C.A., Peng, J.W., Bemis, G.W., Ajay, Murcko, M.A., and Moore, J.M. The SHAPES strategy: an NMR-based approach for lead generation in drug discovery. Chem. Biol. 1999. 6(10: 755-769.
24. Bemis, G.W. and Murcko, M.A. The properties of known drugs. 1. Molecular frameworks. J. Med. Chem. 1996. 39: 2887-2893.
25. Liu, B., Li, S. and Hu, J. Technological Advances in High-Throughput Screening. Am J Pharmacogenomics 2004; 4 (4): 263-276.
26. Okerberg ES, Wu J, Zhang B, Samii B, Blackford K, Winn DT, Shreder KR, Burbaum JJ, Patricelli MP. High-resolution functional proteomics by active-site peptide profiling. Proc Natl Acad Sci U S A. 2005. 102(14):4996-5001.
27. Burbaum J, Tobal GM. Proteomics in drug discovery. Curr. Opin. Chem. Biol. 2002. 6(4):427-33.
28. Nedelkov D, Phillips DA, Tubbs KA, Nelson RW. Investigation of human protein variants and their frequency in the general population. Mol. Cell. Proteomics. 2007 Jul;6(7):1183-1187.
29. Sturtevant JM. Heat capacity and entropy changes in processes involving proteins. Proc Natl Acad Sci U S A. 1977. 74:2236-40.
30. Doyle, M.L. Characterization of binding interactions by isothermal titration calorimetry. Curr. Opin., Biotechnol. 1997. 8:31-35.
31. Todd, M.J., Gomez, J. Enzyme kinetics determined using calorimetry: A general assay for enzyme activity? Anal. Biochem. 2001. 296, 179-187.
32. Schön, A., Ingaramo, M. and Freire, E. The binding of HIV-1 protease inhibitors to human serum proteins. Biophys. Chem. 2003. 105 (2-3): 221-230.
33. Bonincontro, A., Cinelli, S., Mengoni, M., Onori, G., Risuleo, G. and Santucci, A. Differential stability of E. coli ribosomal particles and free RNA towards thermal degradation studied by microcalorimetry. Biophys. Chem. 1998. 75 (2): 97-103.
34. Stolarski, R. Thermodynamics of specific protein-RNA interactions. Acta Biochimica Polonica. 2003. 50(2): 297-318.
35. Haney, S., LaPan, P. Pan, J. and Zhang, J. High-conent screening moves to the front of the line. Drug Discov. Today.2006. 11(19/20): 889-894.
36. Giuliano, KA., DeBiasio, RL, Dunlay, RT., Gough, A. Volosky JM., Zock, J., Pavlakis, G.N., and Taylor, D.L. High content screening: a new approach to easing key bottlenecks in the drug discovery process. J. Biomol. Screen. 1997. 2:249-259.
37. Gough, A.H. and Johnston, PA., Requirements, features, and performance of high content screening platforms. Methods Mol. Biol. 2007. 356: 41-61
38. Stegmaier, K., Ross, KN., Colavito, S., O'Malley, S., Stockwell, B.R. and Golub, T.R. Gene expression based high-throughput screening (GE-HTS) and applications to leukemia differentiation. Nat Genet. 2004. 36: 257-263.
39. Rausch, O. High content screening. Curr. Opin. Chem. Biol. 2006. 10: 316-320.
40. Cooper, M.A. Non-optical screening platforms: the next wave in label-free screening? Drug Discov. Today. 2006. 11(23/24): 1068-1074.
41. Valet, G. Cytomics as a new potential for drug discovery. Drug Discov. Today. 2006. 11 (17/18):785-791.
42. Korn, K. and Krausz, E. Cell-based high-content screening of small-molecule libraries. Curr. Opin. Chem. Biol. 2007. 11:503-510.
43. Gough, A.H. and Johnston, P.A., Requirements, features, and performance of high content screening platforms. Methods Mol. Biol. 2007. 356:41-61.
44. Shelat, A. A. and Guy, R.K. The interdependence between screening methods and screening libraries. Curr. Opin. Chem. Biol. 2007. 11:244-251.
45. Solly, K., Wang, X., Xu, X., Strulovici, B. and Zheng, W. Application of real-time cell electronic sensing (TRT-CES) technology to cell based assays. Assay and Drug Development Tech. 2004. 2(4): 363-373.
46. Hoa, X.D., Kirk, A.G. and Tabrizian, M. Towards integrated and sensitive surface plasmon resonance biosensors: A review of recent progress. Biosensensors & Bioelectronics. 2007. 23: 151-160.
47. Ramsden, J.J. Optical Biosensors. J. Mol. Recogn. 1997. 10: 109-120.
48. Homola, J, S.S. Yee, G. Gauglitz. Surface plasmon resonance sensors: review. Sensors and Actuators. B 54 (1999). 3-15.
49. Gauglitz, G. and Proll, G. Strategies for label-free optical detection. Adv. Biochem. Engin. Biotechnol. 2008. 109:395-432.
50. Cooper, M. A. Optical biosensors: where next and how soon? Drug Discov. Today 11(23/24): 1061-1067.
51. Rich, R.L. and Myszka, D.G. Higher-throughput, label-free, real-time molecular interaction analysis. Anal. Biochem. 2007. 361:1-6.
52. Yuk, J.S. and Ha, K-S. Proteomic applications of surface plasmon resonance biosensors: analysis of protein array. Exp. Mol. Med. 2005. 37(1): 1-10.
53. Fang, Y. Label-free cell based assays with optical biosensors in drug discovery. Assay Drug Dev. Tech. 2006. 4(5):583-595.
54. Neumann, T., Junker, H.D., Schmidt, K. and Sekul, R. SPR-based fragment screening: advantages and applications. Curr. Top. Med. Chem. 2007. 7(16): 1630-1642.
55. Yuen, P.K., Fontaine, N.H., Quesada, M., Mazumder, P., Bergman, R. and Mozdy, E.J. Self-referencing a single waveguide grating sensor in a micron-sized deep flow chamber for label-free biomolecular binding assays. Lab Chip. 2005. 5:959-965.
56. Chen, X., Davies, M.C., Roberts, C., Shakesheff, K.M., Tendler, S.J.B., and Williams, P.M. Dynamic surface events measured by simultaneous probe microscopy and surface plasmon detection. Anal. Chem. 1996. 68: 1451-1455.
57. Nedelkov D. Development of surface plasmon resonance mass spectrometry array platform. Anal. Chem. 2007. 79(15):5987-90.
58. Szunerits S, Knorr N, Calemczuk R, Livache T. New approach to writing and simultaneous reading of micropatterns: combining surface plasmon resonance imaging with scanning electrochemical microscopy (SECM). Langmuir. 2004. 20(21):9236-41.
59. Ly N, Foley K, Tao N. Integrated label-free protein detection and separation in real time using confined surface plasmon resonance imaging. Anal. Chem. 2007. 79(6):2546-2551.
60. Boecker D, Zybin A, Horvatic V, Grunwald C, Niemax K. Differential surface plasmon resonance imaging for high-throughput bioanalyses. Anal. Chem. 2007. 79(2):702-9.
61. Brolo AG, Kwok SC, Cooper MD, Moffitt MG, Wang CW, Gordon R, Riordon J, Kavanagh KL. Surface plasmon-quantum dot coupling from arrays of nanoholes. J Phys Chem B. 2006. 110(16): 8307-8313.
62. Levene MJ, Korlach J, Turner SW, Foquet M, Craighead HG, Webb WW. Zero-mode waveguides for single-molecule analysis at high concentrations. Science. 2003. 299: 682-686.
63. Mandal, S. and Erickson, D. Nanoscale optofluidic sensor arrays. Optics Express. 2008. 16(3): 1623-1631.
64. Cunin F, Schmedake TA, Link JR, Li YY, Koh J, Bhatia SN, Sailor MJ. Biomolecular screening with encoded porous-silicon photonic crystals. Nat Mater. 2002. 1(1):39-41.
65. Link, JR and Sailor MJ. Smart dust: self-assembling, self-orienting photonic crystals of porous Si. Proc Natl Acad Sci U S A. 2003. 100(19):10607-10.
66. Ramachandran N, Larson DN, Stark PR, Hainsworth E, LaBaer J. Emerging tools for real-time label-free detection of interactions on functional protein microarrays. FEBS J. 2005. 272(21): 5412-25.
67. Lee KL, Lee CW, Wang WS, Wei PK. Sensitive biosensor array using surface plasmon resonance on metallic nanoslits. J Biomed Opt. 2007. 12(4): 044023.
68. Lee KG, Park QH. Coupling of surface plasmon polaritons and light in metallic nanoslits. Phys. Rev. Lett. 2005. 95(10): 103902.
69. Hossein-Zadeh, M. and Vahala, K. Free ultra-high-Q microtoroid: a tool for designing photonic devices. Optics express. 2007. 15 (1): 166-175.
70. Yonath A. Molecular biology: triggering positive competition. Nature. 2006 444(7118):435-6.
71. Cencic R, Robert F, Pelletier J. Identifying small molecule inhibitors of eukaryotic translation initiation. Methods Enzymol. 2007. 431:269-302.
72. Auerbach T, Bashan A, Yonath A. Ribosomal antibiotics: structural basis for resistance, synergism and selectivity. Trends Biotechnol. 2004. 22(11):570-6.
73. Wilson DN, Harms JM, Nierhaus KH, Schlünzen F, Fucini P. Species-specific antibiotic-ribosome interactions: implications for drug development. Biol. Chem. 2005 386(12):1239-1252.
74. Hansen JL, Moore PB, Steitz TA. Structures of five antibiotics bound at the peptidyl transferase center of the large ribosomal subunit. J Mol Biol. 2003. 330(5):1061-75.
75. Muralidharan V, Muir TW. Protein ligation: an enabling technology for the biophysical analysis of proteins. Nat Methods. 2006. 3(6):429-38.
76. Lee KH, Joung HA, Ahn JH, Kim KO, Oh IS, Shin YB, Kim MG, Kim DM. Real-time monitoring of cell-free protein synthesis on a surface plasmon resonance chip. Anal Biochem. 2007. 366(2):170-4.
77. Tabuchi M, Hino M, Shinohara Y, Baba Y. Cell-free protein synthesis on a microchip Proteomics. 2002. 2(4):430-5.
78. Kawasaki T, Gouda MD, Sawasaki T, Takai K, Endo Y. Efficient synthesis of a disulfide-containing protein through a batch cell-free system from wheat germ. Eur J Biochem. 2003. 270(23):4780-4786.
79. Robelek R, Lemker ES, Wiltschi B, Kirste V, Naumann R, Oesterhelt D, Sinner EK. Incorporation of in vitro synthesized GPCR into a tethered artificial lipid membrane system. Angew Chem Int Ed Engl. 2007. 46(4):605-8.
80. Mack, G. MicroRNA gets down to business. Nature Biotech. 2007. 25 (6): 631-638.
81. Meister G. miRNAs get an early start on translational silencing. Cell. 2007. 131(1):25-28.
82. Thermann R, Hentze MW. Drosophila miR2 induces pseudo-polysomes and inhibits translation initiation. Nature. 2007. 447(7146):875-878.
83. Fang S, Lee HJ, Wark AW, Corn RM. Attomole microarray detection of microRNAs by nanoparticle-amplified SPR imaging measurements of surface polyadenylation reactions. J Am Chem. Soc. 2006. 128(43):14044-14046
84. Wark AW, Lee HJ, Corn RM. Multiplexed detection methods for profiling microRNA expression in biological samples. Angew. Chem Int. Ed. 2008. 47(4):644-52.
85. Lee HJ, Li Y, Wark AW, Corn RM. Enzymatically amplified surface plasmon resonance imaging detection of DNA by exonuclease III digestion of DNA microarrays. Anal Chem. 2005. 77(16):5096-100.
86. L'pez-Otín, C. and Overall, C.M. Protease Degradomics: A New Challenge For Proteomics. Nature Reviews. 2002. (3):509-519.
87. Overall, C.M. Dilating the degradome: matrix metalloproteinase 2 (MMP-2) cuts to the heart of the matter. Biochem. J. 2004. 1: 383: e5-7. Review
88. Hershko, A.V. Ubiquitin Mediated Protein degradation. Minireview. J. Biol. Chem. 1988. 263. 30: 15237-15240.
89. Cal, S., Quesada, V., Garabaya, C. and L'pez-Otín, C. Polyserase-I, a human polyprotease with the ability to generate independent serine protease domains from a single translation product. PNAS. 2003. 100 (16): 9185-9190.
90. Folgueras, A.R., Pendas, A.M., Sanchez, L.M. and L'pez-Otín, C. Amtrix Metalloproteinases in cancer: from new functions to improved inhibition strategies. Int. J. Dev. Biol. 2004. 48: 411-424.
91. Overall, C.M., Tam, E.M., Kappelhoff, R. Connor, A., Ewart, T., Morrison, C.J., Puente, X., L'pez-Otín, C and Seth, A. Protease Degradomics: mass spectrometry discovery of protease substrates and the CLIP-CHIP, a dedicated DNA microarray of all human proteases and inhibitors. Biol. Chem. 2004. 385:493-504.
92. Bogdanovic, S. and Langlands, B., Proteases. Technology and opportunities for drug discovery. D& MD publications. Drug and Market Report. 2005. Report 9158
93. O'Malley SM, Xie X, Frutos AG. Label-free high-throughput functional lytic assays. J Biomol. Screen. 2007. 12(1):117-125.
94. Frostell-Karlsson, A., Remaeus, A., Roos, H., Andersson, K., Borg, P., Hämäläinen, M. and Karlsson, R. Biosensor analysis of the interaction between immobilized human serum albumin and drug compounds for prediction of human serum albumin binding levels. J. Med. Chem. 2000. 43, 1986-1992.
95. Rich, R.L., Hoth, L.R., Geoghegan, K.F., Brown, T.A., LaMotte, P.K., Simons, S.P., Hensley, P., Myszka, D.G. Kinetic analysis of estrogen receptor/ligand interactions. Proc. National. Acad. Sci. 2002. 99(13): 8562-8567.
96. Hämäläinen, M.D., Markgren, P-O, Schaal, W., Karlén, A. and Danielson, U.H. Characterization of a set of HIV-1 protease inhibitors using binding kinetics data from a biosensor-based screen. J. Biomol. Screening. 2000. 5(5): 353-359.
97. Sumner, C., Krause, S., Sabot, A., Turner, K. and McNeil, C.J. Biosensor based on enzyme-catalyzed degradation of thin polymer films. Biosensor and Bioelectronics. 2001. 16: 709-714.
98. Lin, B., Gerstenmeier, J., Li, P., Pien, H., Pepper, J., and Cunningham, B. A label-fee optical technique for detecting small molecule interactions. Biosensor and Bioelectronics. 2002. 17: 827-834.
99. Kim, J-H., Roy, S. Kellis Jr., J.T., Poulose, A.J., Gast, A.P. and Robertson, C. R. Protease adsorption and reaction on an immobilized substrate. Langmuir. 2002. 18, 6312-6318.
100. Lee, H.J., Wark, A.W., Goodrich, T.T., Fang, S. and Corn, R.M. Surface enzyme kinetics for biopolymer microarrays: a combination of Langmuir and Michaelis-Menten Concepts. Langmuir. 2005, 21, 4050-4057.
101. Hartmann-Petersen R, Gordon C. Quantifying protein-protein interactions in the ubiquitin pathway by surface plasmon resonance. Methods Enzymol. 2005. 399: 164-77.
102. Oh YH, Hong MY, Jin Z, Lee T, Han MK, Park S, Kim HS. Chip-based analysis of SUMO (small ubiquitin-like modifier) conjugation to a target protein. Biosens Bioelectron. 2007. 22(7):1260-1270.
103. Yuk, J.S. and Ha, K-S., Proteomic applications of surface plasmon resonance biosensors: analysis of protein arrays. Exp. Mol. Med. 2005. 37 (1): 1-10.
104. O'Malley SM, Sattar AK, Williams KR, Spicer EK. Mutagenesis of the COOH-terminal region of bacteriophage T4 regA protein. J Biol Chem. 1995. 270(10):5107-14.
105. Sota H, Hasegawa Y, Iwakura M. Detection of conformational changes in an immobilized protein using surface plasmon resonance. Anal Chem. 1998. 70(10):2019-24.
106. Gestwicki JE, Hsieh HV, Pitner JB. Using receptor conformational change to detect low molecular weight analytes by surface plasmon resonance. Anal Chem. 2001. 73(23):5732-7.
107. Honjo E, Watanabe K, Tsukamoto T. Real-time kinetic analyses of the interaction of ricin toxin A-chain with ribosomes prove a conformational change involved in complex formation. J Biochem. 2002. 131(2):267-75.
108. Robelek R, Lemker ES, Wiltschi B, Kirste V, Naumann R, Oesterhelt D, Sinner EK. Incorporation of in vitro synthesized GPCR into a tethered artificial lipid membrane system. Angew Chem. Int Ed Engl. 2007. 46(4):605-608.
109. Von der Haar T, Oku Y, Ptushkina M, Moerke N, Wagner G, Gross JD, McCarthy JE. Folding transitions during assembly of the eukaryotic mRNA cap-binding complex. J Mol Biol. 2006. 356(4):982-92.
110. Waks M, Yip YK, Beychok S. Influence of prosthetic groups on protein folding and subunit assembly. Recombination of separated human alpha-and beta-globin chains with heme and alloplex interactions of globin chains with heme-containing subunits. J Biol Chem. 1973. 248(18):6462-70.
111. Fermi G, Perutz MF, Shaanan B, Fourme R. The crystal structure of human deoxyhaemoglobin at 1.74 A resolution. J. Mol. Biol. 1984. 175(2):159-74.
112. Rossi-Fanelli A, Antonini E, Caputo A. Pure native globin from human hemoglobin: preparation and some physico-chemical properties. Biochim Biophys Acta. 1958. 28(1):221.
113. Ascoli F, Fanelli MR, Antonini E. Preparation and properties of apohemoglobin and reconstituted hemoglobins. Methods Enzymol. 1981. 76:72-87.
114. Groves, K., Wilson, A.J. and Hamilton, A.D. Catalytic unfolding and proteolysis of cytochrome c induced by synthetic binding agents. J. Am. Chem. Soc. (2004) 126:12833-12842.
115. Ptushkina M, von der Haar T, Vasilescu S, Frank R, Birkenhäger R, McCarthy JE. Cooperative modulation by eIF4G of eIF4E-binding to the mRNA 5' cap in yeast involves a site partially shared by p20. EMBO J. 1998. 17(16):4798-808.
116. Karlsson M, Pavlov MY, Malmqvist M, Persson B, Ehrenberg M. Initiation of Escherichia coli ribosomes on matrix coupled mRNAs studied by optical biosensor technique. Biochimie. 1999. 81(10):995-1002.
117. Bargis-Surgey P, Lavergne JP, Gonzalo P, Vard C, Filhol-Cochet O, Reboud JP. Interaction of elongation factor eEF-2 with ribosomal P proteins. Eur J Biochem. 1999 Jun;262(2):606-11.
118. Ishino T, Atarashi K, Uchiyama S, Yamami T, Saihara Y, Yoshida T, Hara H, Yokose K, Kobayashi Y, Nakamura Y. Interaction of ribosome recycling factor and elongation factor EF-G with E. coli ribosomes studied by the surface plasmon resonance technique. Genes Cells. 2000. 5(12):953-63.
119. Dominguez D, Kislig E, Altmann M, Trachsel H. Structural and functional similarities between the central eukaryotic initiation factor (eIF)4A-binding domain of mammalian eIF4G and the eIF4A-binding domain of yeast eIF4G. Biochem J. 2001. 355(Pt 1):223-30.
120. Ptushkina M, Berthelot K, von der Haar T, Geffers L, Warwicker J, McCarthy JE. A second eIF4E protein in Schizosaccharomyces pombe has distinct eIF4G-binding properties. Nucleic Acids Res. 2001. 15; 29(22):4561-4569.
121. Iwasaki K, Kikukawa S, Kawamura S, Kouzuma Y, Tanaka I, Kimura M. On the interaction of ribosomal protein L5 with 5S rRNA. Biosci Biotechnol Biochem. 2002. 66(1):103-9.
122. Petrushenko ZM, Budkevich TV, Shalak VF, Negrutskii BS, El'skaya AV. Novel complexes of mammalian translation elongation factor eEF1A.GDP with uncharged tRNA and aminoacyl-tRNA synthetase. Implications for tRNA channeling. Eur J Biochem. 2002. 269(19):4811-8.
123. Honjo E, Watanabe K, Tsukamoto T. Real-time kinetic analyses of the interaction of ricin toxin A-chain with ribosomes prove a conformational change involved in complex formation. J Biochem. 2002. 131(2):267-75.
124. Mandon EC, Jiang Y, Gilmore R. Dual recognition of the ribosome and the signal recognition particle by the SRP receptor during protein targeting to the endoplasmic reticulum. J Cell Biol. 2003. 162(4):575-85.
125. von der Haar T, Hughes JM, Manjarul Karim M, Ptushkina M, McCarthy JE. Translation initiation and surface plasmon resonance: new technology applied to old questions. Biochem Soc Trans. 2002. 30(2):155-162.
126. Nakano H, Yoshida T, Uchiyama S, Kawachi M, Matsuo H, Kato T, Ohshima A, Yamaichi Y, Honda T, Kato H, Yamagata Y, Ohkubo T, Kobayashi Y. Structure and binding mode of a ribosome recycling factor (RRF) from mesophilic bacterium. J Biol Chem. 2003. 278(5):3427-36.
127. Komarova AV, Real E, Borman AM, Brocard M, England P, Tordo N, Hershey JW, Kean KM, Jacob Y. Rabies virus matrix protein interplay with eIF3, new insights into rabies virus pathogenesis. Nucleic Acids Res. 2007. 35(5):1522-32.
128. von der Haar T, Oku Y, Ptushkina M, Moerke N, Wagner G, Gross JD, McCarthy JE. Folding transitions during assembly of the eukaryotic mRNA cap-binding complex. J Mo.l Biol. 2006. 356(4):982-92
129. Lee KH, Joung HA, Ahn JH, Kim KO, Oh IS, Shin YB, Kim MG, Kim DM. Real-time monitoring of cell-free protein synthesis on a surface plasmon resonance chip. Anal. Biochem. 2007. 366(2):170-4.